(Q37275962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Matthias Girndt

series ordinal

1

1 reference

19 August 2017

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

823-840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18808207%20AND%20SRC:MED&resulttype=core&format=json

Impaired function of macrophage Fc gamma receptors in end-stage renal disease

14 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200825100-00002

An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200825100-00002

Immunizations for pediatric transplant patients.

21 January 2018

1 reference

12 December 2020

Impact of hepatitis B and C virus on kidney transplantation outcome

1 reference

12 December 2020

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

1 reference

12 December 2020

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

1 reference

12 December 2020

A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

1 reference

12 December 2020

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

1 reference

12 December 2020

Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis

1 reference

12 December 2020

Section VI. Haemodialysis-associated infection

1 reference

12 December 2020

1 reference

12 December 2020

Clinical relevance of age-related immune dysfunction

1 reference

12 December 2020

Interferon treatment for chronic hepatitis C virus infection in uremic patients

1 reference

12 December 2020

Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.

1 reference

12 December 2020

Diagnosis, management, and treatment of hepatitis C

1 reference

12 December 2020

The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis

1 reference

12 December 2020

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

12 December 2020

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

1 reference

12 December 2020

Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

1 reference

12 December 2020

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

12 December 2020

Immune response to influenza vaccination in a large healthy elderly population

1 reference

12 December 2020

Interferon treatment for chronic hepatitis C in haemodialysis patients: suggestions based on a small series

1 reference

12 December 2020

Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect

1 reference

12 December 2020

Hepatitis C screening strategies in hemodialysis patients

1 reference

12 December 2020

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

1 reference

12 December 2020

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

1 reference

12 December 2020

Interferon treatment for hepatitis C virus infection in patients on haemodialysis

1 reference

12 December 2020

Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment

1 reference

12 December 2020

Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination

1 reference

12 December 2020

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

1 reference

12 December 2020

Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection

1 reference

12 December 2020

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 December 2020

Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses

1 reference

12 December 2020

Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure

1 reference

12 December 2020

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

12 December 2020

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

12 December 2020

Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

1 reference

12 December 2020

Interferon-alpha in chronic hepatitis C infection in dialysis patients

1 reference

12 December 2020

High-flux membranes are not permeable to hepatitis B virus-DNA

1 reference

12 December 2020

Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality

1 reference

12 December 2020

Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis

1 reference

12 December 2020

Recommendations for preventing transmission of infections among chronic hemodialysis patients

1 reference

12 December 2020

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

12 December 2020

Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study

1 reference

12 December 2020

The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection

1 reference

12 December 2020

Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-up

1 reference

12 December 2020

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

1 reference

12 December 2020

The use of vaccines in adult patients with renal disease

1 reference

12 December 2020

Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level

1 reference

12 December 2020

Hepatitis C virus infection

1 reference

12 December 2020

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

1 reference

12 December 2020

Expanded CD4+ and CD8+ T cell clones in elderly humans

1 reference

12 December 2020

Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection

1 reference

12 December 2020

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients

1 reference

12 December 2020

Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit

1 reference

12 December 2020

Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?

1 reference

12 December 2020

Cell death and longevity: implications of Fas-mediated apoptosis in T-cell senescence

1 reference

12 December 2020

Immunopathogenesis in hepatitis C virus cirrhosis

1 reference

12 December 2020

Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients

1 reference

12 December 2020

High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy

1 reference

12 December 2020

Severe evolution of chronic hepatitis C in renal transplantation: a case control study

1 reference

12 December 2020

Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C

1 reference

12 December 2020

Efficacy of interferon-alpha in the treatment of chronic hepatitis C in dialysis patients: two therapeutic protocols compared

1 reference

12 December 2020

The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells

1 reference

12 December 2020

Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients.

1 reference

12 December 2020

Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients

1 reference

12 December 2020

HCV infection and hemodialysis.

1 reference

12 December 2020

Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.

1 reference

12 December 2020

Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.

1 reference

12 December 2020

Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group

1 reference

12 December 2020

Infection control in hemodialysis units.

1 reference

12 December 2020

T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure

1 reference

12 December 2020

Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency

1 reference

12 December 2020

T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway

1 reference

12 December 2020

Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease

1 reference

12 December 2020

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

1 reference

12 December 2020

Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis

1 reference

12 December 2020

Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production

1 reference

12 December 2020

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials

1 reference

12 December 2020

Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

1 reference

12 December 2020

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

12 December 2020

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype

1 reference

12 December 2020

An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation

1 reference

12 December 2020

Biological dynamics of hepatitis B virus load in dialysis population

1 reference

12 December 2020

Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.

1 reference

12 December 2020

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation

1 reference

12 December 2020

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

12 December 2020

Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis

1 reference

12 December 2020

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation

1 reference

12 December 2020

Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C

1 reference

12 December 2020

Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells.

1 reference

12 December 2020

The tolerance and efficacy of interferon‐α in haemodialysis patients with HCV infection: a multicentre, prospective study

1 reference

12 December 2020

Interferon therapy for patients more than 60 years of age with chronic hepatitis C.

1 reference

12 December 2020

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

12 December 2020

Biological basis for the clinical use of interferon

1 reference

12 December 2020

Active hepatitis B vaccination of dialysis patients and medical staff

1 reference

12 December 2020

Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea?

1 reference

12 December 2020

Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group

1 reference

12 December 2020

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

1 reference

12 December 2020

Hepatitis C virus infection in kidney transplant recipients

1 reference

12 December 2020

Aging and proinflammatory cytokines

1 reference

12 December 2020

Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

1 reference

12 December 2020

Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?

1 reference

12 December 2020

A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection

1 reference

12 December 2020

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study

1 reference

12 December 2020

Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection

1 reference

12 December 2020

Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.

1 reference

12 December 2020

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

1 reference

12 December 2020

Survival of hepatitis B virus after drying and storage for one week

1 reference

12 December 2020